ViroGates A/S (CPH:VIRO)
10.60
+0.10 (0.95%)
May 27, 2026, 4:43 PM CET
ViroGates Revenue
ViroGates had revenue of 1.30M DKK in the quarter ending March 31, 2026, with 8.40% growth. This brings the company's revenue in the last twelve months to 9.01M, up 32.27% year-over-year. In the year 2025, ViroGates had annual revenue of 8.90M with 24.67% growth.
Revenue (ttm)
9.01M
Revenue Growth
+32.27%
P/S Ratio
10.93
Revenue / Employee
1.29M
Employees
7
Market Cap
98.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.90M | 1.76M | 24.67% |
| Dec 31, 2024 | 7.14M | 155.00K | 2.22% |
| Dec 31, 2023 | 6.99M | -8.21M | -54.02% |
| Dec 31, 2022 | 15.20M | 6.95M | 84.27% |
| Dec 31, 2021 | 8.25M | 2.89M | 54.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| Genmab | 25.29B |
| ALK-Abelló | 6.56B |
| Gubra | 2.64B |
| Scandinavian Medical Solutions | 214.99M |
| BioPorto | 40.29M |
| Stenocare | 9.24M |
ViroGates News
- 20 days ago - ViroGates Quarterly report: Q1 2026 - Filings
- 2 months ago - ViroGates Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - ViroGates Annual report: Q4 2025 - Filings
- 7 months ago - ViroGates Earnings Call Transcript: Q3 2025 - Transcripts
- 7 months ago - ViroGates Quarterly report: Q3 2025 - Filings
- 9 months ago - ViroGates Quarterly report: Q2 2025 - Filings
- 1 year ago - ViroGates Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - ViroGates Quarterly report: Q1 2025 - Filings